The BRAF V600E mutation in papillary thyroid cancer with positive or suspected pre-surgical cytological finding is not associated with advanced stages or worse prognosis

By Barbaro Daniele   Incensati Roberto   Materazzi Gabriele   Boni Giuseppe   Grosso Mariano   Panicucci Erica   Lapi Paola   Pasquini Cristina   Miccoli Paolo  

Endocrine, Vol. 45, Iss. 3, 2014-04 ,pp. : 462-468

Springer Publishing Company

Access to resources Recommend Favorite

Presence of the BRAF V600E point mutation in morphologically benign appearing thyroid inclusions of cervical lymph nodes

By Mojica Wilfrido   Khoury Thaer  

Endocrine Pathology, Vol. 17, Iss. 2, 2006-06 ,pp. : 183-189

Humana Press, Inc

Access to resources Recommend Favorite

BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis

By Sargent Rachel   LiVolsi Virginia   Murphy Justin   Mantha Geeta   Hunt Jennifer  

Endocrine Pathology, Vol. 17, Iss. 3, 2006-09 ,pp. : 235-241

Humana Press, Inc

Access to resources Recommend Favorite

Follicular, Papillary, and “Hybrid” Carcinomas of the Thyroid

By Castro Patrícia   Fonseca Elsa   João Magalhães João   Sobrinho-Simões Manuel  

Endocrine Pathology, Vol. 13, Iss. 4, 2002-12 ,pp. : 313-320

Humana Press, Inc

Access to resources Recommend Favorite

BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?

By Puxeddu Efisio   Filetti Sebastiano  

Endocrine, Vol. 45, Iss. 3, 2014-04 ,pp. : 341-343

Springer Publishing Company

Access to resources Recommend Favorite